• 不 限
  • 期刊论文
  • 硕博论文
  • 会议论文
  • 报 纸
  • 英文论文
  2. 您的位置
  3. 首页
  4. 会议论文
  5. High-dose methotrexate in the mobilization of hematopoietic stem cells for patients with non-Hodgkin

High-dose methotrexate in the mobilization of hematopoietic stem cells for patients with non-Hodgkin

来源 :The 35th World Congress of the International Society of Hema | 被引量 : 0次 | 上传用户：kekedala
【摘 要】
：
Background High-dose chemotherapy followed by autologous hematopoietic stem cell transplantation (auto-HSCT) is a promising approach for non-Hodgkins lymphoma (NHL).Higher cell doses have been associa
【作 者】
：
Cheng Zhang Xing-Hua Chen Li Gao Yao Liu Lei Gao Pei-Yan Kong Dong-Feng Zeng Xian-Gui Peng Ai-Hua Sun Xi Zhang 
【机 构】
：
Department of Hematology,Xinqiao Hospital,Third Military Medical University,Chongqing
【出 处】
：
The 35th World Congress of the International Society of Hema
【发表日期】
：
2014年5期
下载到本地 , 更方便阅读
下载此文 赞助VIP
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background High-dose chemotherapy followed by autologous hematopoietic stem cell transplantation (auto-HSCT) is a promising approach for non-Hodgkins lymphoma (NHL).Higher cell doses have been associated with a faster blood count recovery and a reduction in transfusion requirements,infection rates and hospitalization times.
其他文献
Splenectomy improves anemia but does not reduce iron burden in patients with haemoglobin H Constant
Background.Alpha thalassaemia is a congenital hemolytic disease caused by disorders of α globin synthesis due to the deletions or mutations within the genes that encode α globin chain.Splenectomy is r
会议
Updated Outcomes of NF-08-TM Protocol in HSCT for Patients with β-thalassemia Mjor A Large Sample Pr
Background The optimization of both erythrocyte transfusion and iron chelating has resulted in a remarkable improvement in the life expectancy of patients with thalassemia major (TM).However,only cura
会议
Sustained Response Subsequent to a Short-course of Recombinant Human Thrombopoietin (rhTPO) in Immun
Background TPO-mimetic agents are definite second-line management for ITP patients promoting development and maturation of megakaryocyte lineage.Platelet count usually drops back to baseline level wit
会议
Abnormalities of quantities and functions of Linker for Activations of T cells (LAT) in severe aplas
Objective This study aims at understanding the role of lymphocyte LAT in SAA.Methods The expression of LAT,related signaling molecules and T cell effector molecules was determined by flow cytometry.LA
会议
TNF-α Enhances Vascular Cell Adhesion Molecule-1 Expression in Human Bone Marrow Mesenchymal Stem Ce
Objective Observe the effect of TNF-α on the VCAM-1expression of human BMSCs and the relationship between them.And explore the relationship among these three signaling pathways and the effect of TNF-α
会议
Platelet-derived serotonin stimulates TPO released from bone marrow mesenchymal stromal cells in bot
Objective The bone marrow (BM) microenvironment plays an important role in regulation of thrombopoiesis through release of thrombopoietic growth factor,among which thrombopoietin (TPO) is the most ess
会议
Donor CD8+ T cells preferentially damaged thymic mTEC and caused defective thymic selection early af
(1)Donor CD8+ T cells preferentially damaged thymic mTEC early after HCT.Lethally irradiated BALB/c recipients were transplanted with donor C57BL/6 TBCD-BM(2.5 x 106)and 0.1 x106 donor CD4+ or CD8+ T
会议
IL-22 aggravates murine acute graft-versus-host disease by expanding effector T cell and reducing re
Graft-versus-host disease (GVHD) as a major complication after allo-geneic hamatopoietic stem cell transplantation (allo-HSCT) is not well prevented now.We have observed that IL-22 produced by Th22,Th
会议
Alteration of serum levels of proinflammatory chemokines CCL2 and CXCL2 is correlated with pathologi
Graft versus host disease (GVHD) is the major complication associated with allogeneic hematopoietic stem cell transplantation (allo-HSCT).Chemokines are well known inducers of leukocyte trafficking an
会议
Allogeneic Compact Bone-derived Mesenchymal Stem Cell Transplantation Attenuates the Severity of Idi
Idiopathic pneumonia syndrome (IPS) is a serious and life-threatening lung complication following allogeneic hematopoietic stem cell transplantation (allo-HSCT) and currently no effective therapies ex
会议